{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:24:18Z","timestamp":1787901858769,"version":"build-2784847793"},"reference-count":30,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bladder and urothelial carcinoma are marked by profound genomic diversity. Using a large, multi-institutional dataset, we performed comprehensive genomic profiling of 4631 tumor samples from 4050 individuals. A retrospective analysis of bladder and urothelial cancer was performed using the AACR Project GENIE database. Demographic associations, mutation frequencies, copy number changes, and survival correlations were analyzed with a p-value &lt; 0.05. Frequent mutations were identified in TP53, TERT, KDM6A, KMT2D, ARID1A, and FGFR3. Mutation frequencies varied by sex and race, with specific alterations enriched in female and Asian patients. Distinct patterns of co-occurrence, including TP53 with RB1, and mutual exclusivity, including TP53 with FGFR3 or KDM6A, revealed distinct molecular subtypes. This study highlights the extensive heterogeneity of bladder cancer, and our findings emphasize the clinical importance of molecular stratification and support the need for further mechanistic and prospective studies to inform the development of targeted therapies.<\/jats:p>","DOI":"10.3390\/ijms262311653","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:49:22Z","timestamp":1764665362000},"page":"11653","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genomic Characteristics of Bladder Cancer: An AACR Project GENIE Study"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7503-5298","authenticated-orcid":false,"given":"John Paul","family":"Braun","sequence":"first","affiliation":[{"name":"School of Medicine, Creighton University, Omaha, NE 68178, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6743-0710","authenticated-orcid":false,"suffix":"Jr.","given":"Kenneth A. D.","family":"Palattao","sequence":"additional","affiliation":[{"name":"School of Medicine, Creighton University, Omaha, NE 68178, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Torbenson","sequence":"additional","affiliation":[{"name":"School of Medicine, Creighton University, Omaha, NE 68178, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6403-502X","authenticated-orcid":false,"given":"Beau","family":"Hsia","sequence":"additional","affiliation":[{"name":"School of Medicine, Creighton University, Phoenix, AZ 85012, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar","family":"Tauseef","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Creighton University, Omaha, NE 68178, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"ref_1","unstructured":"Durowoju, L., and Tretiakova, M. (2025, September 01). Invasive Urothelial Carcinoma. Pathology Outlines. Available online: https:\/\/www.pathologyoutlines.com\/topic\/bladderurothelialinvasivegen.html."},{"key":"ref_2","first-page":"32","article-title":"News in the classification of WHO 2022 bladder tumors","volume":"115","author":"Raspollini","year":"2023","journal-title":"Pathologica"},{"key":"ref_3","unstructured":"Symptoms of Bladder Cancer (2025, September 01). nhs.uk. Available online: https:\/\/www.nhs.uk\/conditions\/bladder-cancer\/symptoms\/."},{"key":"ref_4","unstructured":"Bladder Cancer Treatment and Survival Rate (2025, September 01). City of Hope. Available online: https:\/\/www.cityofhope.org\/clinical-program\/bladder-cancer\/treatments-survival."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.21037\/atm-20-2108","article-title":"An overview of patients with urothelial bladder cancer over the past two decades: A Surveillance, Epidemiology, and End Results (SEER) study","volume":"8","author":"Zang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10732748231152322","DOI":"10.1177\/10732748231152322","article-title":"Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004-2015","volume":"30","author":"Lin","year":"2023","journal-title":"Cancer Control"},{"key":"ref_7","unstructured":"Bladder Cancer (2025, September 01). Cancer Research UK. Available online: https:\/\/www.cancerresearchuk.org\/about-cancer\/bladder-cancer."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e995","DOI":"10.1016\/j.clgc.2019.05.008","article-title":"Racial and socioeconomic disparities in bladder cancer survival: Analysis of the California Cancer Registry","volume":"17","author":"Sung","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_9","unstructured":"Bladder Cancer (2025, September 01). Cleveland Clinic. Available online: https:\/\/my.clevelandclinic.org\/health\/diseases\/14326-bladder-cancer."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41416-020-01157-0","article-title":"Fibroblast growth factor receptors in cancer: Genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance","volume":"124","author":"Krook","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pignot, G., Barth\u00e9l\u00e9my, P., and Borchiellini, D. (2024). Sex Disparities in Bladder Cancer diagnosis and Treatment. Cancers, 16.","DOI":"10.3390\/cancers16234100"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","article-title":"Biological differences underlying sex and gender disparities in bladder cancer: Current synopsis and future directions","volume":"12","author":"Doshi","year":"2023","journal-title":"Oncogenesis"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sekino, Y., Nakahara, H., Ikeda, K., Kobatake, K., Kohada, Y., Tasaka, R., Takemoto, K., Miyamoto, S., Kitano, H., and Goto, K. (2025). The Gender-Biased differential Effect of KDM6A mutation on immune therapy in urothelial carcinoma: A public database study. Cancers, 17.","DOI":"10.3390\/cancers17030356"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12967-020-02308-w","article-title":"Ethnicity and survival in bladder cancer: A population-based study based on the SEER database","volume":"18","author":"Fang","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/1878-0261.13360","article-title":"Integrated analysis of racial disparities in genomic architecture identifies a trans-ancestry prognostic subtype in bladder cancer","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41588-024-02030-z","article-title":"Comprehensive genomic characterization of early-stage bladder cancer","volume":"57","author":"Prip","year":"2025","journal-title":"Nat. Genet."},{"key":"ref_17","unstructured":"(2025, September 01). GDC Analysis Center, Available online: https:\/\/portal.gdc.cancer.gov\/analysis_page?app=MutationFrequencyApp."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","article-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","volume":"39","author":"Fujii","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.18632\/oncotarget.27988","article-title":"Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors","volume":"12","author":"Dhar","year":"2021","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2012.46.5740","article-title":"Prevalence and Co-Occurrence of actionable genomic alterations in High-Grade Bladder Cancer","volume":"31","author":"Iyer","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e8261","DOI":"10.7717\/peerj.8261","article-title":"Significance of TP53 mutation in bladder cancer disease progression and drug selection","volume":"7","author":"Wu","year":"2019","journal-title":"PeerJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exphem.2020.04.007","article-title":"Epigenetic regulation of protein translation in KMT2A-rearranged AML","volume":"85","author":"Lenard","year":"2020","journal-title":"Exp. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Li, L., Li, M., Jiang, Z., and Wang, X. (2019). ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer. Cells, 8.","DOI":"10.3390\/cells8070678"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dimitrov, G., Mangaldzhiev, R., Slavov, C., and Popov, E. (2024). Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative review. Cancers, 16.","DOI":"10.3390\/cancers16173056"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cai, L., DeBerardinis, R.J., Xiao, G., Minna, J.D., and Xie, Y. (2022). A Pan-Cancer assessment of RB1\/TP53 Co-Mutations. Cancers, 14.","DOI":"10.3390\/cancers14174199"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.eururo.2020.07.018","article-title":"Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma","volume":"78","author":"Teo","year":"2020","journal-title":"Eur. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trecan.2019.11.004","article-title":"Mutant p53 on the Path to Metastasis","volume":"6","author":"Tang","year":"2019","journal-title":"Trends Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Thompson, D., Lawrentschuk, N., and Bolton, D. (2023). New approaches to targeting epigenetic regulation in bladder Cancer. Cancers, 15.","DOI":"10.3390\/cancers15061856"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/LCTT.S493835","article-title":"Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC","volume":"16","author":"Arter","year":"2025","journal-title":"Lung Cancer Targets Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11653\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:51:51Z","timestamp":1764665511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":30,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311653"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311653","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}